Biomedical engineering

Then after a short period working in industry, I decided to do a PhD.

I moved to University of Patras in Greece, where I did a PhD in Biomedical Engineering.

But during the PhD, I became very interested in what are essentially inverse problems.

So you have an observation which is noisy or incomplete, and you want to infer what produced it.

Yep.

Uh, there's the UBC School of Biomedical Engineering-

Yeah.

Yep

Dr. Hoff is Professor and Executive Director of Faculty Development and Academic Affairs in the Department of Anesthesiology, Perioperative and Pain Medicine.

She's Adjunct Professor of Biomedical Engineering and Co-Director of the University of Utah Coaching and Advancement Network at the University of Utah.

Dr. Hoff has more than 100 publications.

Her research, which was supported by the NIH for over 20 years, focuses on surgical site infection prevention and reducing the environmental impact of infection control, as well as gender equity and professionalism.

So that was one thing that sort of allows faculty voice to be better transmitted to the dean, to the executive vice president.

And then the second thing was we took a look at our adjunct faculty, which at the time there was one job code for adjunct faculty, but it covered a lot of different things.

Like I have an adjunct appointment in biomedical engineering, which is unpaid, but I'm internal to the university.

But we really wanted to focus on, we have all these clinical preceptors in the community who were called adjunct faculty at the time.

And I am very pleased to have you with us, Dr. Al, because you are actually a twice-over graduate alum of Syracuse University, which is very exciting.

You were specifically in our biomedical engineering program at Syracuse.

So just to start off our conversation, I'm interested about what drew you to studying biomedical engineering for your graduate program.

Yeah, that's a fantastic question.

So biomedical engineering has been an ongoing developing field.

So really combining the facets from biology and really the engineering aspects, mathematics.

So really understanding the impact of the cellular environment and the impact it can have on different products, whether it's biological products, medical devices, or even in the biopharmaceutical industry as it's continued to evolve.

So really, the avenue of focusing on biomedical engineering went back to being able to help people, but not necessarily in the medical field itself, not dealing directly with patients.

This episode features Jennifer Kalit Barton, a professor and Thomas R.

Brown Distinguished Chair of Biomedical Engineering at the University of Arizona.

Her research focuses on development of optical techniques for understanding disease processes with an emphasis on ovarian cancer.

She's had a storied career that started with bachelor's and master's degrees in electrical engineering before earning her PhD in biomedical engineering.

Jennifer is also involved with the National Institute of Biomedical Imaging and Bioengineering and is a past president of SPIE.

She's produced over 150 peer-reviewed manuscripts and eight patents, graduated 35 master's and PhD students, and as a principal investigator, she's led 25 grants totaling more than $23 million.

Why don't you tell me about your work?

I do have a lot of appointments.

And having my discussions with him helped drive that.

Uh, but our, the way we look at data, the way we collect data probably differs because we, thanks to our amazing team at, at Wisdom, at N1, at Biomedical Engineering, the way we collect data is different because we look at capability versus just more data points over time.

And what about the public, um, reaction to what you did? The moment you posted a biological age of 32, the internet peanut gallery immediately started asking what you take.

So some people assume you take, um, t- testosterone replacement, HGH, or a mountain of supplements.